Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · S

S. 773 (104th)

Animal Drug Availability Act of 1996

openUnited States· United States Congress· EN

Introduced

9 May 1995

Last action

26 September 1996 · Floor

Status

Held at the desk.

Sponsors

Sen. Kassebaum, Nancy Landon [R-KS], Sen. Gregg, Judd [R-NH], Sen. Gorton, Slade [R-WA], Sen. Coats, Daniel [R-IN], Sen. Jeffords, James M. [I-VT], Sen. Frist, William H. [R-TN], Sen. Harkin, Tom [D-IA], Sen. Craig, Larry E. [R-ID], Sen. Lugar, Richard G. [R-IN], Sen. Inhofe, James M. [R-OK], Sen. Grassley, Chuck [R-IA], Sen. McConnell, Mitch [R-KY], Sen. Kyl, Jon [R-AZ], Sen. Santorum, Rick [R-PA], Sen. Heflin, Howell [D-AL], Sen. Bond, Christopher S. [R-MO], Sen. Pryor, David H. [D-AR], Sen. Kerrey, J. Robert [D-NE], Sen. Bennett, Robert F. [R-UT], Sen. Helms, Jesse [R-NC], Sen. Hutchison, Kay Bailey [R-TX], Sen. Lott, Trent [R-MS], Sen. Dole, Robert J. [R-KS], Sen. Bumpers, Dale [D-AR], Sen. Mack, Connie, III [R-FL], Sen. Ashcroft, John [R-MO], Sen. Cochran, Thad [R-MS], Sen. Roth Jr., William V. [R-DE], Sen. Warner, John [R-VA], Sen. Ford, Wendell H. [D-KY], Sen. Kempthorne, Dirk [R-ID], Sen. Robb, Charles S. [D-VA], Sen. Pressler, Larry [R-SD], Sen. Nickles, Don [R-OK], Sen. Stevens, Ted [R-AK], Sen. Abraham, Spencer [R-MI], Sen. Daschle, Thomas A. [D-SD], Sen. Grams, Rod [R-MN], Sen. Conrad, Kent [D-ND], Sen. Burns, Conrad R. [R-MT], Sen. Moseley-Braun, Carol [D-IL], Sen. Dorgan, Byron L. [D-ND], Sen. Baucus, Max [D-MT], Sen. Hatch, Orrin G. [R-UT], Sen. Coverdell, Paul [R-GA]

Subjects

Healthcare

Source updated

21 April 2025

Healthcare

Summary

Animal Drug Availability Act of 1995 - Amends Federal Food, Drug, and Cosmetic Act provisions relating to new animal drugs to redefine "substantial evidence" to mean evidence from one or more scientifically sound studies including, as appropriate, in vitro studies, studies in laboratory animals, bioequivalence studies, tissue residue studies, and any studies voluntarily undertaken by or for the applicant that provide some assurance that the drug will have the intended effect. Excludes a claim for the use of a drug in a minor species or a minor use of a drug from disapproval, if there is an application filed for the drug which is approved prior to the submission of the claim. Directs the Secretary of Health and Human Services to consider the following issues when a new animal drug contains more than one active ingredient, or the labeling of the drug suggests use of the drug in combination with another animal drug: (1) whether any active ingredient or any combination of drugs alters the safe concentration of another of the active ingredients or drugs in the combination; (2) whether each of the active ingredients or drugs in the combination have been shown to contribute to the same intended effect; and (3) whether each of the active ingredients or drugs in the combination has an identified target population for which dosing with the active ingredients or combination represents appropriate concurrent therapy. Requires the Secretary to issue proposed regulations implementing the provisions of this section which: (1) further define "substantial evidence"; (2) take into account the proposals contained in the citizen petition submitted by the American Veterinary Association and the Animal Health Institute; (3) provide for a conference to make a decision establishing a submission or an investigational requirement; and (4) define the kinds of evidence an applicant may use to establish the contribution of each active ingredient and to establish the appropriateness of concurrent therapy in a new animal drug, or new animal drug used in combination with another drug. (Sec. 4) Requires the Secretary to approve or disapprove the application within 90 (currently 180) days of receipt of the application. (Sec. 5) Requires: (1) the Secretary to refer disputed issues received in writing from an applicant to an advisory committee or to a special Government employee; and (2) the committee or employee to submit a report containing recommendations regarding the matter. (Sec. 6) Requires the Secretary to refuse approval of an application if information submitted with respect to the drug indicates that any use suggested in labeling proposed for that drug will result in a unsafe amount of residue. (Sec. 7) Permits the export of an unsafe (as defined in the Act) new animal drug, if it is not in conflict with the laws of the country to which it is exported. (Currently, such export is prohibited.)

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 9 May 1995

    Introduced

    Read twice and referred to the Committee on Labor and Human Resources.

    Source: IntroReferral

  2. 9 May 1995

    Introduced

    Introduced in Senate

    Source: IntroReferral

  3. 9 May 1995

    Introduced

    Sponsor introductory remarks on measure. (CR S6351-6352)

    Source: IntroReferral

  4. 24 September 1996

    Floor

    Measure laid before Senate. (consideration: CR S11204-11209)

    Source: Floor

  5. 24 September 1996

    Passed

    Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.

    Source: Floor

  6. 24 September 1996

    Discharge

    Senate Committee on Labor and Human Resources discharged by Unanimous Consent.

    Source: Discharge

  7. 24 September 1996

    Committee

    Senate Committee on Labor and Human Resources discharged by Unanimous Consent.

    Source: Committee

  8. 26 September 1996

    Floor

    Held at the desk.

    Source: Floor

  9. 26 September 1996

    Floor

    Message on Senate action sent to the House.

    Source: Floor

  10. 26 September 1996

    Floor

    Received in the House.

    Source: Floor

Votes

No vote records are attached yet.

Versions

Documents

6 official files

Engrossed in Senate (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Engrossed in Senate (text)

    Engrossed in Senate · EN · 24 September 1996

    ViewDownloadOpen at official source

  • Engrossed in Senate (PDF)

    Engrossed in Senate · EN · 24 September 1996

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Passed Senate amended

    summary · EN · 24 September 1996

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate (text)

    Introduced in Senate · EN · 9 May 1995

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate (PDF)

    Introduced in Senate · EN · 9 May 1995

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate

    summary · EN · 9 May 1995

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.